Abstract
4754 Background: Cox-2 is over expressed in patients (pts) with HRPC and is an independent predictor of survival. C is a Cox-2 inhibitor. E is a derivative of doxorubicin with lower cardiotoxicity....
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have